Oxford BioDynamics (LON:OBD) Reaches New 12-Month Low – What’s Next?

Oxford BioDynamics Plc (LON:OBD) shares hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 0.48 ($0.01) and last traded at GBX 0.50 ($0.01), with a volume of 16868893 shares changing hands. The stock had previously closed at GBX 0.55 ($0.01).

Oxford BioDynamics Stock Down 9.1 %

The company has a quick ratio of 2.80, a current ratio of 0.68 and a debt-to-equity ratio of 370.22. The company has a market capitalization of £1.56 million, a PE ratio of -8.33 and a beta of 0.42. The stock has a 50-day moving average of GBX 1.07 and a 200 day moving average of GBX 3.13.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.